Monoclonal Antibodies

Oct 7, 2020Podcast0 comments

There are now two companies awaiting approval for monoclonal antibody treatments which have been found to be effective in decreasing the severity of COVID-19 when administered early.

Send in a voice message:


Submit a Comment

Your email address will not be published. Required fields are marked *